Deep-dive AI research reports on individual stocks, powered by our proprietary signals. Every report carries a direction (Bullish or Bearish) and a conviction level(Strong or Speculative). We track stock performance since each report's publication date — because we believe great analysis should be held accountable.

The Dark Pool Anatomy of Krystal Biotech’s Breakout

2026-05-05BullishStrongChange from report: +7.8%

Krystal Biotech's breakout to $286.95 was driven by institutional dark pool activity, not just strong Q1 2026 earnings. Analysis of off-exchange data reveals a setup of extreme shorting preceding the engineered price move.